Skip to main content
. 2021 Nov 18;7(11):000696. doi: 10.1099/mgen.0.000696

Table 4.

Summary of resistance determinants for MLSB antimicrobials

Gene

Clade distribution [N (%)]

Overall

C1

C2

C3

C4

C5

Cryptic

ermB

953 (14.2%)

421 (21.6%)

0 (0.0%)

328 (58.9%)

73 (8.6%)

0 (0.0%)

1776 (17.2%)

 Tn5398

168 (2.5%)

1 (0.1%)

0 (0.0%)

0 (0.0%)

1 (0.1%)

0 (0.0%)

170 (1.6%)

 Tn6189

259 (3.9%)

104 (5.3%)

0 (0.0%)

44 (7.9%)

17 (2.0%)

0 (0.0%)

424 (4.1%)

 Tn6194

204 (3.0%)

270 (13.8%)

0 (0.0%)

268 (48.1%)

46 (5.4%)

0 (0.0%)

788 (7.6%)

 Tn6215

106 (1.6%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

2 (0.2%)

0 (0.0%)

108 (1.0%)

 Tn6218

200 (3.0%)

4 (0.2%)

0 (0.0%)

10 (1.8%)

2 (0.2%)

0 (0.0%)

216 (2.1%)

 Unknown

16 (0.2%)

42 (2.2%)

0 (0.0%)

6 (1.1%)

5 (0.6%)

0 (0.0%)

69 (0.7%)

Other erm genes

86 (1.3%)

17 (0.9%)

1

(0.4%)

66 (11.8%)

4 (0.5%)

0 (0.0%)

175 (1.7%)

Non-erm genes

76 (1.1%)

104 (5.3%)

1 (0.4%)

22 (3.9%)

18 (2.1%)

0 (0.0%)

222 (2.1%)